Skip to main content
. Author manuscript; available in PMC: 2017 Jan 2.
Published in final edited form as: Liver Int. 2015 Jun 3;35(12):2575–2583. doi: 10.1111/liv.12872

Table 3.

Risk of cardiovascular disease mortality after liver transplantation for NASH

Risk Groupa Population N (%) Deaths N (%) Hazard Ratio (95% CI) P value
Low (0–1 point) 1453 (28.7) 42 (2.9) Reference
Intermediate (2 points) 1984 (39.2) 80 (4.0) 1.42 (0.98, 2.07) 0.064
High (3–4 points) 1461 (28.9) 93 (6.4) 2.36 (1.64, 3.40) <0.001
Very High (5 points) 159 (3.1) 13 (8.2) 3.34 (1.79, 6.23) <0.001
a

Each patient was classified according to how many risk factors they had pretransplant: Age ≥ 55 (1 point), male sex (1 point), diabetes (1 point), renal impairment (2 points), defined as estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73 m2 or need for renal replacement therapy

C-statistic = 0.60 (95% CI 0.59–0.62), after bootstrapping